Compare FDC LTD. with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs CIPLA - Comparison Results

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. CIPLA FDC LTD./
CIPLA
 
P/E (TTM) x 16.1 23.4 68.6% View Chart
P/BV x 2.2 2.4 90.9% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 FDC LTD.   CIPLA
EQUITY SHARE DATA
    FDC LTD.
Mar-18
CIPLA
Mar-19
FDC LTD./
CIPLA
5-Yr Chart
Click to enlarge
High Rs319678 47.1%   
Low Rs164484 33.9%   
Sales per share (Unadj.) Rs61.6198.2 31.1%  
Earnings per share (Unadj.) Rs9.918.5 53.7%  
Cash flow per share (Unadj.) Rs12.035.0 34.2%  
Dividends per share (Unadj.) Rs03.00 0.0%  
Dividend yield (eoy) %00.5 0.0%  
Book value per share (Unadj.) Rs73.2186.3 39.3%  
Shares outstanding (eoy) m174.40805.70 21.6%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x3.92.9 133.7%   
Avg P/E ratio x24.331.4 77.4%  
P/CF ratio (eoy) x20.216.6 121.6%  
Price / Book Value ratio x3.33.1 105.9%  
Dividend payout %016.2 0.0%   
Avg Mkt Cap Rs m42,118468,031 9.0%   
No. of employees `0005.522.6 24.4%   
Total wages/salary Rs m2,16728,565 7.6%   
Avg. sales/employee Rs Th1,943.77,053.1 27.6%   
Avg. wages/employee Rs Th391.71,261.5 31.1%   
Avg. net profit/employee Rs Th313.7659.1 47.6%   
INCOME DATA
Net Sales Rs m10,751159,710 6.7%  
Other income Rs m5104,766 10.7%   
Total revenues Rs m11,260164,475 6.8%   
Gross profit Rs m2,26730,973 7.3%  
Depreciation Rs m35113,263 2.6%   
Interest Rs m141,684 0.8%   
Profit before tax Rs m2,41120,791 11.6%   
Minority Interest Rs m-5-172 2.8%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6715,695 11.8%   
Profit after tax Rs m1,73514,924 11.6%  
Gross profit margin %21.119.4 108.7%  
Effective tax rate %27.827.4 101.6%   
Net profit margin %16.19.3 172.7%  
BALANCE SHEET DATA
Current assets Rs m7,213124,266 5.8%   
Current liabilities Rs m2,10437,715 5.6%   
Net working cap to sales %47.554.2 87.7%  
Current ratio x3.43.3 104.1%  
Inventory Days Days5491 60.1%  
Debtors Days Days2895 29.2%  
Net fixed assets Rs m6,865105,190 6.5%   
Share capital Rs m1751,611 10.9%   
"Free" reserves Rs m12,586148,511 8.5%   
Net worth Rs m12,761150,123 8.5%   
Long term debt Rs m638,301 0.0%   
Total assets Rs m15,041239,633 6.3%  
Interest coverage x173.213.3 1,298.1%   
Debt to equity ratio x00.3 0.2%  
Sales to assets ratio x0.70.7 107.2%   
Return on assets %11.66.9 167.8%  
Return on equity %13.69.9 136.8%  
Return on capital %19.011.8 160.2%  
Exports to sales %12.334.7 35.6%   
Imports to sales %00-   
Exports (fob) Rs m1,32755,419 2.4%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,88957,410 3.3%   
Fx outflow Rs m019,041 0.0%   
Net fx Rs m1,88938,368 4.9%   
CASH FLOW
From Operations Rs m1,49816,911 8.9%  
From Investments Rs m201-16,687 -1.2%  
From Financial Activity Rs m-1,694-3,487 48.6%  
Net Cashflow Rs m10-3,451 -0.3%  

Share Holding

Indian Promoters % 68.9 16.0 430.6%  
Foreign collaborators % 0.0 20.8 -  
Indian inst/Mut Fund % 4.7 12.2 38.5%  
FIIs % 7.5 23.7 31.6%  
ADR/GDR % 0.0 1.1 -  
Free float % 19.0 26.2 72.5%  
Shareholders   23,730 161,166 14.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   JUBILANT LIFE SCIENCES  PANACEA BIOTECH  CADILA HEALTHCARE  ABBOTT INDIA  PLETHICO PHARMA  

Compare FDC LTD. With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 93 Points Higher; Oil & Gas and Realty Stocks Witness Buying(Closing)

Indian share markets traded on a volatile note throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the oil & gas sector.

Related Views on News

CIPLA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 9, 2019 | Updated on Sep 9, 2019

Here's an analysis of the annual report of CIPLA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

CIPLA Announces Quarterly Results (1QFY20); Net Profit Up 5.6% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CIPLA has posted a net profit of Rs 5 bn (up 5.6% YoY). Sales on the other hand came in at Rs 40 bn (up 1.3% YoY). Read on for a complete analysis of CIPLA's quarterly results.

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

CIPLA Announces Quarterly Results (4QFY19); Net Profit Up 144.0% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, CIPLA has posted a net profit of Rs 4 bn (up 144.0% YoY). Sales on the other hand came in at Rs 44 bn (up 19.1% YoY). Read on for a complete analysis of CIPLA's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Oct 16, 2019 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. 8-QTR ANALYSIS

COMPARE FDC LTD. WITH

MARKET STATS